Skip to main content
. 2017 Dec 9;9(1):576–590. doi: 10.18632/oncotarget.23076

Figure 1. Characterization of rat BMSCs.

Figure 1

Flow Cytometric surface marker expression profile showed cells expressed CD29, CD44 and CD90 and were negative for CD45 and CD11b.